Neurologia
Estudo de coorte retrospectiva | Avaliação retrospectiva de desfechos oftalmológicos e neurológicos em bebês nascidos antes de 24 semanas de idade gestacional.
9 Ago, 2022 | 17:06h
Revisão | Adultos com deficiência intelectual e transtornos de saúde mental na atenção primária.
9 Ago, 2022 | 16:47h
Melhorando a prevenção de AVC primário: uma abordagem combinada.
5 Ago, 2022 | 17:43hEnhancing primary stroke prevention: a combination approach – The Lancet Public Health
Comentário no Twitter
Primary #stroke #prevention strategies target behavioural and pharmacological approaches. Also need to manage structural factors that support or hinder prevention actions and behaviours. @StrokeImperial @Simzy_x @Tsering_ @SomaBanerjee73 @CFCFoundation
https://t.co/vyyhhfeg7Y pic.twitter.com/kqwF9DROG2— Joseph Kwan, MD 🇬🇧 (@drjkwan) July 31, 2022
Sob licença de Creative Commons Attribution (CC BY 4.0)
Estudo randomizado | Estimulação transcraniana por corrente contínua vs. tratamento simulado para tratamento de desatenção em adultos com transtorno de déficit de atenção/hiperatividade.
5 Ago, 2022 | 17:16hTranscranial Direct Current Stimulation vs Sham for the Treatment of Inattention in Adults With Attention-Deficit/Hyperactivity Disorder: The TUNED Randomized Clinical Trial – JAMA Psychiatry (gratuito por tempo limitado)
Ver também: Visual Abstract
Estudo randomizado | Comparação da mudança para dose a cada 6 semanas de natalizumabe vs. continuar a dose a cada 4 semanas em pacientes com esclerose múltipla recorrente-remitente.
5 Ago, 2022 | 17:05hComparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial – The Lancet Neurology (link para o resumo – $ para o texto completo)
Comentário: Less Frequent Dosing With MS Drug Safe With No Loss of Efficacy – Medscape (necessário cadastro gratuito)
Estudo randomizado | Efeito do retreinamento gradual sensoriomotor sobre a intensidade da dor em pacientes com dor lombar crônica.
5 Ago, 2022 | 16:29hEffect of Graded Sensorimotor Retraining on Pain Intensity in Patients With Chronic Low Back Pain: A Randomized Clinical Trial – JAMA (gratuito por tempo limitado)
Comunicado de imprensa: An effective new treatment for chronic back pain targets the nervous system – University of New South Wales
Comentário no Twitter
A graded sensorimotor retraining intervention, compared with a sham procedure and attention control, resulted in a statistically significant improvement in pain intensity at 18 weeks. https://t.co/MXO89JeOSe pic.twitter.com/0A865RWW85
— JAMA (@JAMA_current) August 2, 2022
Estudo de coorte retrospectiva | Síncope e o risco de subsequente de acidente automobilístico.
4 Ago, 2022 | 14:25hSyncope and the Risk of Subsequent Motor Vehicle Crash: A Population-Based Retrospective Cohort Study – JAMA Internal Medicine (gratuito por tempo limitado)
Editorial: Driving Safety After an Acute Illness—This Is Our Lane – JAMA Internal Medicine (gratuito por tempo limitado)
Comentário no Twitter
"I fainted…am I safe to drive?" Study found that 9,223 drivers with an ED visit for syncope had subsequent crash risks no different than controls, suggesting more stringent driving restrictions might not be justified. https://t.co/T0GUJ63Nci
— JAMA Internal Medicine (@JAMAInternalMed) August 1, 2022
Estudo de coorte | Associação de amiloide elevado e sinal de PET tau com desenvolvimento, no curto prazo, de sintomas de doença de Alzheimer em idosos sem comprometimento cognitivo.
4 Ago, 2022 | 14:21hAssociation of Elevated Amyloid and Tau Positron Emission Tomography Signal With Near-Term Development of Alzheimer Disease Symptoms in Older Adults Without Cognitive Impairment – JAMA Neurology (link para o resumo – $ para o texto completo)
Comentário no Twitter
Study found that Aβ and tau PET positivity in cognitively unimpaired individuals was associated with near-term progression to mild cognitive impairment and, among those who do not show such categorical change, longitudinal cognitive decline. https://t.co/sKpST7e4Nh
— JAMA Neurology (@JAMANeuro) July 30, 2022
Recomendações de consenso sauditas sobre tratamento de esclerose múltipla em crianças e adolescentes.
4 Ago, 2022 | 14:15h
Estudo de coorte | Rápida perda do olfato prediz demência e menores áreas cerebrais ligadas à doença de Alzheimer.
2 Ago, 2022 | 12:55hComunicado de imprensa: Rapid loss of smell predicts dementia and smaller brain areas linked to Alzheimer’s – University of Chicago Medical Center
Estudo original: Rapid olfactory decline during aging predicts dementia and GMV loss in AD brain regions – Alzheimer’s & Dementia